the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Russia’s election panel refuses to register Putin opponent

MOSCOW: The Russian Central Election Commission has refused to register anti-Kremlin journalist Yekaterina Duntsova’s initiative group for the presidential election on March 17, reported German news agency (dpa).

The commission announced in Moscow on Saturday that there had been several errors in the organisation of the initiative group and in the documents submitted.

The 40-year-old Duntsova had previously criticised Russian President Vladimir Putin’s policies and war against Ukraine, and offered herself to voters as an alternative. She would have needed the initiative group to obtain signatures of support to register as a candidate for the presidency.

According to Duntsova’s supporters, individual misspellings of names were interpreted as “serious errors” in the documents.

The head of the election commission, Ella Pamfilova, is considered a close confidante of Putin. “You are a young woman, you still have everything ahead of you. Every minus can be turned into a plus. Every experience is an experience,“ she said addressing Duntsova.

Russian state media had previously linked the journalist to exiled Putin opponent Mikhail Khodorkovsky.

Putin’s opponents are repeatedly complaining that the election commission is rejecting the registration of candidates with formal errors.

It is expected that candidates who do not represent serious competition for the incumbent will on the contrary be admitted to the upcoming presidential election.

It is considered certain that Putin will also emerge victorious in his fifth run at the presidency.

The Russian president had the Constitution amended specifically in order to be able to run again. According to the current version of the Constitution, the 71-year-old can run for the last time in 2030. The presidential term of office in Russia is six years. – Bernama, dpa

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings